Direct Thrombin Inhibitors
Direct thrombin inhibitors prevent cleavage of fibrinogen to fibrin, and are therefore very effective anticoagulants.
|Uses||VTE prophylaxis, AF|
|Route of Administration||PO|
|Dosing||VTE: 220mg daily, AF: 150mg BD|
|Distribution||35% protein bound|
|Metabolism||Prodrug - activated by plasma and hepatic esterases|
|Elimination||Renal elimination of active drug|
|Other||Significant interactions with amiodarone, quinidine, St. John's Wort, as well as other anticoagulant and antiplatelet agents. Dialysable. Potentially reversible with Idarucizumab.|
- Smith S, Scarth E, Sasada M. Drugs in Anaesthesia and Intensive Care. 4th Ed. Oxford University Press. 2011.
- Peck TE, Hill SA. Pharmacology for Anaesthesia and Intensive Care. 4th Ed. Cambridge University Press. 2014.